en

PRODUCT DETAIL

Sunitinib MSN 50 mg tvrdé kapsuly

Code 1766E
MA number 44/0078/22-S
Product Form: cps dur 30x50 mg (fľ.HDPE)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EX Other protein kinase inhibitors
L01EX01 Sunitinib
Shelf life: 24
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 09.09.2022
Validity: 09.09.2027
PIL: PIL_Sunitinib MSN 12,5 mg, 25 mg, 37,5 mg, 50 mg cps dur_08_2022.pdf  
SPC: SPC_Sunitinib MSN 12,5 mg, 25 mg, 37,5 mg, 50 mg cps dur_ 08_2022.pdf  
Safety feature Yes
Data update: 21.09.2022
eu-flag.png sk-flag.png